Suppr超能文献

急性心力衰竭中利尿剂使用时间对住院时长和住院死亡率的影响。

The Impact of Door to Diuretic Time in Acute Heart Failure on Hospital Length of Stay and In-Patient Mortality.

作者信息

Iqbal Arshad Muhammad, Mohammed Sohaib K, Zubair Nida, Mubarik Ateeq, Ahmed Adnan, Jamal Syed Farrukh, Hassan Syed Moin, Haq Furqan, Muddassir Salman

机构信息

Internal Medicine, University of South Florida Morsani College of Medicine Graduate Medical Education (GME) Oak Hill Hospital, Brooksville, USA.

Cardiology/Electrophysiology, University of Missouri School of Medicine, Columbia, USA.

出版信息

Cureus. 2021 Jan 16;13(1):e12742. doi: 10.7759/cureus.12742.

Abstract

Background Acute heart failure (AHF) can be life-threatening if not treated promptly and can significantly increase the number of annual emergency department (ED) encounters in the United States. Achieving adequate and prompt euvolemic state in AHF patients using intravenous (IV) diuretics is the cornerstone of treatment, which not only reduces in-hospital stay and mortality but also decreases healthcare expenditures. Surprisingly, the door to diuretic (D2D) time in AHF patients has always been a debatable issue among physicians worldwide, and so far, there are no set guidelines. This study examines a large cohort of AHF patients to determine the association between diuretics use within 90 minutes of ED admission and hospital length of stay (LOS) and patient mortality.  Methods Retrospective institutional data of AHF patients receiving IV diuretics following ED admission were extracted from 2016 to 2017. A total of 7,751 patients treated for AHF exacerbation were included, which were further divided into two groups based on the timing of diuretics administration (<90 minutes vs. ≥90 minutes). The primary outcomes were LOS between the two groups and hospital mortality. The standard statistical methodology was used for data analysis. Results  A total of 7,751 AHF cases receiving IV diuretics were identified. Almost 1,432 patients (18.5%) received IV diuretics within 90 minutes of ER admission (group 1) while 6,319 patients (81.5%) patients received IV diuretics after 90 minutes (group 2). Furthermore, among group 1 patients, average LOS was noted to be associated with shorter hospitalization (average of 1.423 days less as compared to group 2 patients (confidence interval (CI) =1.02-1.82; p<0.05). Finally, after controlling for other mortality risk factors, patients in group 2 were 1.435 times more likely to have died compared to patients in group 1 (CI=1.03-1.98; p<0.05). Conclusions  D2D time in AHF patients has always been a crucial judgmental decision. The current study successfully demonstrated the relation between IV diuretics administration within 90 minutes of ED admission, favorable clinical outcomes, and decreased mortality rates. More adequately powered studies are needed to validate the results of our current study further.

摘要

背景

急性心力衰竭(AHF)若不及时治疗可能危及生命,且会显著增加美国每年急诊科(ED)的就诊人数。使用静脉(IV)利尿剂使AHF患者迅速达到充足的正常血容量状态是治疗的基石,这不仅能缩短住院时间、降低死亡率,还可减少医疗支出。令人惊讶的是,AHF患者的利尿剂给药时间(D2D)在全球医生中一直是个有争议的问题,迄今为止尚无既定指南。本研究调查了一大群AHF患者,以确定急诊入院90分钟内使用利尿剂与住院时间(LOS)和患者死亡率之间的关联。

方法

提取2016年至2017年急诊入院后接受IV利尿剂治疗的AHF患者的回顾性机构数据。总共纳入7751例因AHF加重接受治疗的患者,并根据利尿剂给药时间(<90分钟与≥90分钟)进一步分为两组。主要结局是两组之间的住院时间和医院死亡率。采用标准统计方法进行数据分析。

结果

共识别出7751例接受IV利尿剂治疗的AHF病例。近1432例患者(18.5%)在急诊入院90分钟内接受了IV利尿剂治疗(第1组),而6319例患者(81.5%)在90分钟后接受了IV利尿剂治疗(第2组)。此外,在第1组患者中,平均住院时间与较短的住院时间相关(与第2组患者相比平均少住院日1.423天(置信区间(CI)=1.02-1.82;p<0.05)。最后,在控制其他死亡风险因素后,第2组患者死亡的可能性是第1组患者的1.435倍(CI=1.03-1.98;p<0.05)。

结论

AHF患者的D2D时间一直是一个关键的判断决策。本研究成功证明了急诊入院90分钟内给予IV利尿剂与良好的临床结局和降低死亡率之间的关系。需要更有说服力的研究来进一步验证我们当前研究的结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4666/7884126/a4794c5e3590/cureus-0013-00000012742-i01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验